Argex Mining to Finish Scoping Study of BBA on La Blache Property

Argex Mining Inc. (TSX-V: RGX) (FSE: ASV) (OTCBB: ARGEF) has engaged BBA Inc., one of Canada's leading firms of independent engineering professionals in the mining and metals sector, to complete a scoping study compliant with National Instrument 43-101 Standards of Disclosure for Mineral Projects for the La Blache property.

The scoping study will be comprised of the evaluation of the mining and milling operations and metallurgical processing facility, accompanied by all necessary infrastructures needed for the development of the La Blache property. It is expected that a cost estimate and financial analysis should be completed by March 31, 2011.

The major areas to be covered by the scoping study of BBA include: mine design, general infrastructure, integration of the contributions of third parties (metallurgy, environmental study, market study, transportation study and others), capital and operating cost estimates, cash flow model and financial analysis, and a project implementation schedule.

Argex's objective is to develop a world class titanium mining operation with a hydrometallurgical processing facility treating upwards of three million tonnes per year of ore (3Mtpa); producing high-grade titanium dioxide, iron oxide and vanadium products. The chemical purity of all products is expected to be excellent.

"BBA has put together a highly qualified team of experienced professionals," said Michael Dehn, Argex's President and Chief Excutive Officer, "BBA's multidisciplinary mines and metals group has completed numerous projects related to iron ore, gold and base metals in northern Quebec. We are confident that their involvement in the project is a value-added for our shareholders."

Source: Argex Mining Inc.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.